Goodrx Selling General Administrative from 2010 to 2025

GDRX Stock  USD 4.92  0.27  5.81%   
Goodrx Holdings Selling General Administrative yearly trend continues to be fairly stable with very little volatility. Selling General Administrative is likely to outpace its year average in 2025. During the period from 2010 to 2025, Goodrx Holdings Selling General Administrative regression line of annual values had r-squared of  0.33 and arithmetic mean of  80,465,625. View All Fundamentals
 
Selling General Administrative  
First Reported
2019-09-30
Previous Quarter
27.6 M
Current Value
25.6 M
Quarterly Volatility
70.7 M
 
Covid
Check Goodrx Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Goodrx Holdings' main balance sheet or income statement drivers, such as Interest Income of 35.2 M, Depreciation And Amortization of 130 M or Interest Expense of 39.3 M, as well as many indicators such as Price To Sales Ratio of 4.0, Dividend Yield of 0.0599 or PTB Ratio of 3.94. Goodrx financial statements analysis is a perfect complement when working with Goodrx Holdings Valuation or Volatility modules.
  
Check out the analysis of Goodrx Holdings Correlation against competitors.
For more information on how to buy Goodrx Stock please use our How to Invest in Goodrx Holdings guide.

Latest Goodrx Holdings' Selling General Administrative Growth Pattern

Below is the plot of the Selling General Administrative of Goodrx Holdings over the last few years. It is Goodrx Holdings' Selling General Administrative historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Goodrx Holdings' overall financial position and show how it may be relating to other accounts over time.
Selling General Administrative10 Years Trend
Slightly volatile
   Selling General Administrative   
       Timeline  

Goodrx Selling General Administrative Regression Statistics

Arithmetic Mean80,465,625
Geometric Mean27,230,625
Coefficient Of Variation150.33
Mean Deviation89,341,656
Median8,359,000
Standard Deviation120,960,028
Sample Variance14631.3T
Range453.1M
R-Value0.58
Mean Square Error10457T
R-Squared0.33
Significance0.02
Slope14,660,102
Total Sum of Squares219469.9T

Goodrx Selling General Administrative History

2025166.7 M
2024144.3 M
2023125.5 M
2022144.8 M
2021154.7 M
2020461.5 M
201914.7 M

About Goodrx Holdings Financial Statements

Goodrx Holdings investors use historical fundamental indicators, such as Goodrx Holdings' Selling General Administrative, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Goodrx Holdings. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Selling General Administrative144.3 M166.7 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Goodrx Stock Analysis

When running Goodrx Holdings' price analysis, check to measure Goodrx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Goodrx Holdings is operating at the current time. Most of Goodrx Holdings' value examination focuses on studying past and present price action to predict the probability of Goodrx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Goodrx Holdings' price. Additionally, you may evaluate how the addition of Goodrx Holdings to your portfolios can decrease your overall portfolio volatility.